0.00
price down icon100.00%   -0.2001
 
loading
Schlusskurs vom Vortag:
$0.2001
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$13.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-52.53M
KGV:
0.00
EPS:
-3.66
Netto-Cashflow:
$-39.93M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$0.00
$0.00
52-Wochen-Spanne:
Value
$0.00
$3.10

Unity Biotechnology Inc Stock (UBX) Company Profile

Name
Firmenname
Unity Biotechnology Inc
Name
Telefon
(650) 416-1192
Name
Adresse
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
16
Name
Twitter
@unitybiotech
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
UBX's Discussions on Twitter

Vergleichen Sie UBX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
UBX
Unity Biotechnology Inc
0.00 13.94M 0 -52.53M -39.93M -3.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-27 Herabstufung H.C. Wainwright Buy → Neutral
2025-05-16 Herabstufung Mizuho Outperform → Neutral
2024-08-22 Eingeleitet Rodman & Renshaw Buy
2023-11-16 Hochstufung Wedbush Neutral → Outperform
2022-01-04 Hochstufung ROTH Capital Neutral → Buy
2021-11-10 Hochstufung Mizuho Neutral → Buy
2021-06-28 Hochstufung Citigroup Sell → Buy
2021-06-07 Eingeleitet H.C. Wainwright Buy
2021-02-16 Herabstufung Citigroup Neutral → Sell
2020-08-18 Herabstufung Citigroup Buy → Neutral
2020-08-18 Herabstufung Mizuho Buy → Neutral
2020-08-18 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-08-17 Herabstufung ROTH Capital Buy → Neutral
2020-07-28 Eingeleitet ROTH Capital Buy
2019-12-12 Eingeleitet Cantor Fitzgerald Overweight
2019-03-07 Eingeleitet Cantor Fitzgerald Overweight
2018-09-07 Eingeleitet Mizuho Buy
2018-05-29 Eingeleitet Citigroup Buy
2018-05-29 Eingeleitet Goldman Neutral
2018-05-29 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Unity Biotechnology Inc Aktie (UBX) Neueste Nachrichten

pulisher
Jul 25, 2025

Unity Biotechnology Inc. Stock Analysis and ForecastTriple-digit profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Unity Biotechnology Inc. stock priceFree Bull & Bear Market Updates - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Published on: 2025-07-25 18:10:37 - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

Why Unity Biotechnology Inc. stock attracts strong analyst attentionHigh Potential Safe Trades - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Unity Biotechnology Inc. stockOverwhelming financial success - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

UBX issues 1 share with 600M votes to speed dissolution plan | UBX SEC FilingForm 8-K/A - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Is Unity Biotechnology Inc. a good long term investmentAccelerated wealth building - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Unity Biotechnology Alters Voting Dynamics with New Stock - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

How Unity Biotechnology Inc. stock performs during market volatilityFree Stock Movement Tracking - Newser

Jul 22, 2025
pulisher
Jul 16, 2025

Diabetic Macular Edema Pipeline 2025: MOA, ROA, FDA-Approved Drugs, And Clinical Trial Progress Assessment By Delveinsight Oxurion, Ocuphire Pharma, YD Life Science, Unity Biotechnology, Novartis - MenaFN

Jul 16, 2025
pulisher
Jul 16, 2025

Diabetic Macular Edema Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Oxurion, Ocuphire Pharma, YD Life Science, Unity Biotechnology, Novartis - The Globe and Mail

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Unity Biotechnology Inc. stock price move sharplyFree Access to Investment Community - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Unity Biotechnology, Inc.(NasdaqGS: UBX) dropped from S&P TMI Index - MarketScreener

Jul 10, 2025
pulisher
Jul 09, 2025

New Options Listings and Delistings for July 9th: DTCBD, ECG, EMA, UNBX, DTCB, AKYA, UBX - AInvest

Jul 09, 2025
pulisher
Jul 02, 2025

Unity Biotechnology Plunges 11.08% Amid Clinical Trial Closure, Nasdaq Delisting - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

Unity Biotechnology stock plunges after Nasdaq delisting notice By Investing.com - Investing.com India

Jul 01, 2025
pulisher
Jun 30, 2025

Unity Biotechnology Faces Nasdaq Delisting and Leadership Changes - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution - TradingView

Jun 30, 2025
pulisher
Jun 23, 2025

Future of Aging: Longevity & Anti-senescence Therapy Market to Reach $44.2 Billion by 2030 with 6.1% CAGR - newstrail.com

Jun 23, 2025
pulisher
Jun 20, 2025

Unity Biotechnology Faces Nasdaq Delisting Notice - TipRanks

Jun 20, 2025
pulisher
Jun 14, 2025

Biotech company once valued at $700 million slashes entire workforce - MSN

Jun 14, 2025
pulisher
Jun 12, 2025

Fierce Biotech Layoff Tracker 2025: ADC Tx lets go of 30% of workers; Vertex sheds 125 staffers - Fierce Biotech

Jun 12, 2025
pulisher
Jun 10, 2025

Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews

Jun 10, 2025
pulisher
May 30, 2025

HC Wainwright Issues Optimistic Forecast for UBX Earnings - Defense World

May 30, 2025
pulisher
May 29, 2025

Unity Biotechnology stock hits 52-week low at $0.66 - Investing.com

May 29, 2025
pulisher
May 29, 2025

Unity Biotechnology stock hits 52-week low at $0.66 By Investing.com - Investing.com India

May 29, 2025
pulisher
May 28, 2025

HC Wainwright & Co. Downgrades Unity Biotechnology (LSE:0YC0) - Nasdaq

May 28, 2025
pulisher
May 28, 2025

Unity Biotechnology (NASDAQ:UBX) Receives Neutral Rating from HC Wainwright - Defense World

May 28, 2025
pulisher
May 27, 2025

Unity Biotech stock rating downgraded at H.C. Wainwright By Investing.com - Investing.com South Africa

May 27, 2025

Finanzdaten der Unity Biotechnology Inc-Aktie (UBX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):